The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

about

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

Item

http://www.wikidata.org/entity/Q57816131

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 10 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@en

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@nl

type

Item

label

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@en

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@nl

prefLabel

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@en

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@nl

P1476

The high pCR rate of sandwich ...... e of a Phase II clinical trial

@en

P2093

Gong Chen

http://www.w3.org/2001/XMLSchema#string

Hui Chang

http://www.w3.org/2001/XMLSchema#string

Jia-Wang Wei

http://www.w3.org/2001/XMLSchema#string

Jun-Zhong Lin

http://www.w3.org/2001/XMLSchema#string

Ling-Heng Kong

http://www.w3.org/2001/XMLSchema#string

Mu-Yan Cai

http://www.w3.org/2001/XMLSchema#string

Pei-Qiang Cai

http://www.w3.org/2001/XMLSchema#string

Pei-Rong Ding

http://www.w3.org/2001/XMLSchema#string

Yong-Hong Hu

http://www.w3.org/2001/XMLSchema#string

Zhi-Fan Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.

Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.

Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.

Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

P304

4363-4369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S168573

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Weiwei Xiao

Yuanhong Gao

P577

2018-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349369

http://www.w3.org/2001/XMLSchema#string

P932

6188179

http://www.w3.org/2001/XMLSchema#string